Alan Hruza

Title: Alan Hruza: Innovator in Factor XI Activation Inhibitors

Introduction

Alan Hruza is a notable inventor based in Hackettstown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. His work focuses on innovative solutions for treating thromboses and related disorders.

Latest Patents

Alan Hruza holds 1 patent for his invention titled "Factor XI activation inhibitors." This patent presents a compound of Formula (I) and pharmaceutical compositions that include one or more of these compounds. The methods outlined in the patent are designed for treating or preventing thromboses, embolisms, hypercoagulability, or fibrotic changes. The compounds developed by Hruza are selective Factor XI activation inhibitors, showcasing his expertise in this critical area of medical research.

Career Highlights

Throughout his career, Alan Hruza has worked with prominent companies, including Merck Sharp & Dohme LLC. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Alan Hruza has collaborated with notable professionals in his field, including Jacqueline D Hicks and Amjad Ali. These partnerships have further enriched his research and development efforts.

Conclusion

Alan Hruza's innovative work in the area of Factor XI activation inhibitors highlights his commitment to advancing medical science. His contributions are essential for developing effective treatments for serious health conditions.